| Literature DB >> 35368335 |
Qingli Zhang1, Yangyang Pan1,2, Meng Wang1, Liang Sun1, Yao Xi1, Mei Li1, Qiaoying Zeng1.
Abstract
Bovine endometritis is an inflammatory disease of the uterus that occurs after parturition and can result in the destruction of uterine microecology, disruption of hormone secretion, and even infertility. Problems such as antibiotic residues, pathogen resistance, and microbiota dysbiosis caused by conventional antibiotic therapy cannot be ignored. According to the microecological balance theory, probiotics have the potential to prevent or cure endometritis in cattle. Probiotics can positively influence host physiology by regulating microecological imbalance, modulating immunity, and antagonizing pathogens. Since some probiotics contribute to host health only in their specific natural niches, lactic acid bacteria (LAB) from the vagina may have better potential to fight against vaginal and uterine infection. The yak (Bos grunniens) is an ancient and primitive livestock animal that is adapted to high altitude and harsh environments (cold, nutritional deficiencies, and hypoxia). However, to our knowledge, there have been no studies on yak vaginal LAB. Therefore, the purpose of this study was to isolate vaginal LAB from yak, evaluate and compare the probiotic potential and safety of the isolates, and help establish the probiotics library that can be used in the prevention and/or treatment of endometritis. Twenty-five vaginal swabs were collected from healthy yak and cultured in deMan, Rogosa, and Sharpe (MRS) broth. Tentative LAB strains were preliminarily determined through calcium dissolving zone and morphological identification, and the strains were then identified using 16S rRNA gene sequencing. The probiotics of the isolates were detected using cell aggregation, hydrophobicity, resistance to acid and bile salt, adhesion, and antibacterial activities. Additionally, antimicrobial susceptibility, hemolytic activity, and detection of potential virulence factors were determined in order to confirm the safety of these strains. Five isolates were identified: Leuconostoc mesenteroides, Lactobacillus plantarum, Enterococcus hirae, Lacticaseibacillus camelliae, and Lactobacillus mucosae. All isolates had certain growth resistance, aggregation ability, effective antimicrobial potency against Escherichia coli, Staphylococcus aureus, and Salmonella typhimurium, were sensitive to most antibiotics, and could effectively adhere to bovine endometrial epithelial cells (BEECs). None of the isolates showed hemolytic activity or harbored virulence factors. Our results indicated that the five isolates have considerable potential as probiotics that can be used to prevent and/or treat bovine endometritis. We speculate that a mixture of YD6, YD9, and YD25 may yield better results, although this would require extensive experiments to verify.Entities:
Keywords: Adhesion ability; Antimicrobial activity; BEECs; Endometritis; Lactic acid bacteria; Probiotic; Yak
Year: 2022 PMID: 35368335 PMCID: PMC8973462 DOI: 10.7717/peerj.13177
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
PCR primers, annealing temperatures, and amplicon size used to detect the putative virulence genes in the isolates.
| Primers | Sequences (5’–3’) | Tm (°C) | Amplicon size (bp) | References |
|---|---|---|---|---|
| Ace | Ace-F: CAGGCCAACATCAAGCAACA | 65 | 125 |
|
| Ace-R: GCTTGCCTCGCCTTCTACAA | ||||
| Agg | Agg-F: AAGAAAAAGAAGTAGACCAAC | 53 | 1553 |
|
| Agg-R: AAACGGCAAGACAAGTAAATA | ||||
| Asa1 | Asa1-F: GCACGCTATTACGAACTATGA | 56 | 375 |
|
| Asa-R: TAAGAAAGAACATCACCACGA | ||||
| Cpd | Cpd-F: TGGTGGGTTATTTTTCAATTC | 50 | 782 |
|
| Cpd-R: TACGGCTCTGGCTTACTA | ||||
| CylA | CylA-F: ACTCGGGGATTGATAGGC | 60 | 688 |
|
| CylA-R: GCTGCTAAAGCTGCGCTT | ||||
| ClyB | ClyB-F: ATTCCTACCTATGTTCTGTTA | 56 | 843 |
|
| ClyB-R: AATAAACTCTTCTTTTCCAAC | ||||
| EfaAfs | EfaAfs-F: GACAGACCCTCACGAATA | 56 | 705 |
|
| EfaAfs-R: AGTTCATCATGCTGTAGTA | ||||
| GelE | GelE-F: CGAAGTTGGAAAAGGAGGC | 50 | 372 |
|
| GelE-R: GGTGAAGAAGTTACTCTGA |
Figure 1Phylogenetic tree of five isolates based on the neighbor-joining distance analysis of 16S rRNA gene sequences.
The percentage of autoaggregation and coaggregation with E. coli, S. aureus, and Salm. typhimurium by five isolates.
| Isolates | Autoaggregation | Coaggregation | ||
|---|---|---|---|---|
|
|
|
| ||
| YD6 | 21.24 ± 1.02 d | 18.08 ± 0.94 a | 15.18 ± 0.35 a | 20.32 ± 1.87 a |
Note:
Values expressed as mean ± SD. Different letters represent significant difference, P < 0.05.
Figure 2The hydrophobicity, acid and bile salt resistance, and adhesion ability of LAB isolates.
(A) Hydrophobicity percentages of LAB isolates to xylene, ethylacetate and n-hexadecane. (B) The acid and bile salt tolerance of LAB isolates. (C) Percent adhesion values of LAB to BEECs. Values expressed as mean ± SD. Different letters represent significant difference, P < 0.05.
The inhibition zone diameters (mm) of five strains against E. coli, S. aureus, and Salm. typhimurium.
| Isolates | Indicator pathogens | ||
|---|---|---|---|
| YD6 | 13.63 ± 0.57 ++ b | 13.50 ± 0.50 ++ bc | 14.13 ± 0.32 ++ c |
| YD9 | 16.36 ± 0.55 +++ a | 13.00 ± 0.30 ++ c | 17.86 ± 0.50 +++ a |
| YD14 | 12.33 ± 0.57 ++ c | 14.50 ± 0.55 ++ ab | 14.33 ± 0.57 ++ c |
| YD18 | 15.50 ± 0.51 ++ a | 12.83 ± 0.28 ++ c | 16.23 ± 0.55 +++ b |
| YD25 | 15.93 ± 0.30 ++ a | 14.96 ± 0.89 ++ a | 17.10 ± 0.30 +++ ab |
Note:
Values expressed as mean ± SD. Different letters represent significant difference, P < 0.05.
Figure 3The antibiotic resistance of the LAB isolates against 12 tested antibiotics.
CRO, Ceftriaxone; CIP, ciprofloxacin; AM, ampicillin; R, rifampicin; K, kanamycin; S, streptomycin; TE, tetracycline; GM, gentamicin; C, chloramphenicol; E, erythromycin; CC, clindamycin; CE, cephalothiophene. The total number of LAB strains was taken as 100%. S, sensitive; I, intermediately resistant; R, resistant.
Antibiotic susceptibility of selected LAB strains.
| Strains | Antibiotic susceptibility zone of inhibition in mm | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| YD6 | S | R | S | S | I | S | S | S | S | S | R | S |
| YD9 | S | I | S | S | R | R | S | R | S | S | R | S |
| YD14 | S | I | S | I | R | I | S | S | S | S | S | S |
| YD18 | S | S | S | S | R | R | S | R | S | S | I | S |
| YD25 | S | I | S | R | R | I | S | S | S | S | S | S |
Notes:
CRO, Ceftriaxone; CIP, ciprofloxacin; AM, ampicillin; R, rifampicin; K, kanamycin; S, streptomycin; TE, tetracycline; GM, gentamicin; C, chloramphenicol; E, erythromycin; CC, clindamycin; CE, cephalothiophene. Erythromycin results based on R ≤ 13 mm; I: 13–23 mm; S ≥ 23 mm. Gentamycin results based on R ≤ 6 mm; I: 7–9 mm; S ≥ 10 mm. Streptomycin results based on R ≤ 11 mm; I: 12–14 mm; S ≥ 15 mm. S, susceptible (zone diameter, ≥21); I, intermediate (zone diameter, 15–20 mm); R, resistant (zone diameter, ≤15 mm).